Companies › CSBR

CHAMPIONS ONCOLOGY (CSBR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000771856 · EDGAR filings · Updated 2026-07-27

CHAMPIONS ONCOLOGY (CSBR) has reported institutional ownership of 41.3%, with 25 institutional managers holding positions valued at $33.0M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (2)

• 2026-07-27 — Annual report (10-K) filed
• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-03-30 — Current report (8-K) filed
• 2026-03-12 — Quarterly report (10-Q) filed
• 2026-03-12 — Current report (8-K) filed
• 2026-01-30 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CHAMPIONS ONCOLOGY has 25 institutional holders and institutional ownership of 41.3%.

Insider activity

Insiders reported 2 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

HUMACYTE INC (HUMA) · NUVECTIS PHARMA INC (NVCT) · FRACTYL HEALTH INC (GUTS) · TSCAN THERAPEUTICS INC (TCRX) · LIFEVANTAGE CORP (LFVN) · CELLECTIS S A (CLLS)